ballas invest

Exciting news! Hexoskin has been chosen to contribute its medical technologies and expertise to the future Gateway space station that will orbit the Moon in 2027! 🚀 🌕 The Canadian Space Agency | Agence spatiale canadienne has awarded a contract to Hexoskin this month to adapt the Astroskin wearable vital signs monitoring system for Gateway, a space station that will orbit the Moon. Astroskin wearable sensors monitor 5 vital signs continuously: cardiac activity (ECG), respiratory activity, temperature, blood oxygen (PPG/SpO2), and blood pressure. The convenient form factor allows astronauts to keep working on scientific experiments while participating in clinical trials in space. The Astroskin Bio-Monitor has been in operation aboard the International Space Station National Laboratory (ISS) since January 2019, when it was commissioned by Canadian astronaut David Saint-Jacques. It is currently used in four clinical trials in low Earth orbit focused on studying the cardiorespiratory system and the accelerated aging effect of microgravity on human physiology. The full press release is available here: https://lnkd.in/gK2XHQBm More info on Astroskin: hexoskin.com/astroskin Carré Technologies Inc., NASA - National Aeronautics and Space Administration, European Space Agency - ESA, JAXA: Japan Aerospace Exploration Agency, UAE Space Agency, SpaceX, Blue Origin, Virgin Galactic, Kellie Gerardi, International Institute for Astronautical Sciences (IIAS), American Astronautical Society #spacemedicine #clinicalresearch #wearables #sensors #cardiovascular #respiratory #astroskin #spaceflight #space #exploration

💥 Fière de faire partie des 100 fondatrices invitées ce soir par Les Echos pour célébrer les femmes dans l'entreprenariat 💣 #100fondatrices 👱♀️ Être une femme dans l'entreprenariat c'est avoir l'opportunité immense de construire des entreprises qui changeront l'avenir, en mieux. 🧐 C’est aussi l'occasion de réfléchir à trois choses que je voudrais dire à celles qui voudraient se lancer. 1️⃣ Oui, aujourd'hui encore on fait moins confiance aux femmes pour diriger une entreprise et il vous faudra beaucoup plus prouver votre compétence à tout le monde, tout le temps. 2️⃣ Votre succès dépendra surtout d’à quel point vous consacrez votre énergie avant tout à votre business, et vous ne défendrez jamais aussi bien la cause des femmes qu’en créant de très belles boîtes. 3️⃣ Entreprendre, c’est peut-être avant tout réussir à fédérer des personnes que l’on admire et qui sauront nous apporter de l'excellence, de l'exigence et du soutien. Il ne faut jamais faire de compromis sur la qualité des personnes qui nous entourent. 🤰 Avec Elixir Health, nous travaillons à fonder un monde où les femmes ne seront plus entravées par des parcours médicaux interminables d'infertilité pour fonder une famille, qui les empêchent de vivre leur vie personnelle à fond et de construire de grandes choses professionnellement. 💰 Nous levons des fonds avec Xavier H. et Mathieu Dellenbach, alors si tu es un VC bold enough pour soutenir à la fois une femme fondatrice et une entreprise d'avenir, écris-moi ! Et ne tarde pas trop parce que je suis aussi en train d'imprimer en 3D deux petits garçons de plus 👶 👶 👶 . C'est aussi ça être une femme fondatrice. Merci 🙏 Charlie Perreau 🤳 L'article ici ➡ https://lnkd.in/eCkYaUXP Et merci à tous ceux qui accompagnent notre aventure et m'apportent des ondes positives (non exhaustif !) : Matthieu Masselin Laurent van Lerberghe Joan Larroumec David Lotfi David Gruson Clement Goehrs Griffin Woollgar Stephane Tholander Helene Viatge Franck Mouthon Jean-François Drweski Jonathan Ardouin Noemie Parker Nicolas Princen Hadrien Lanvin Coralie CUIF Nicolas Castoldi Catherine RONGIERES Chadi Yazbeck, MD, PhD Nathalie Massin Félix Mamoudy Dr Jérome BOUAZIZ Elodie ADDA-HERZOG Chahra Louafi Sophie Pellas Jean-Louis Constanza Nicolas Simon Stéphane Barritault Florence Baguet Marie Bascoul Claire Thuillier Romain Vidal Ann-Sofie Perier Ismail Tazi S Guillaume Mallen

🚀 Dedalus and LynxCare: Innovating Clinical Research with AI! 🤝 We’re excited to announce our partnership with LynxCare to enhance Trials For Care (#T4C) and transform clinical research and Real-World Evidence (#RWE) studies. By combining Dedalus’ healthcare expertise with LynxCare’s advanced AI and Natural Language Processing (#NLP) solutions, we’re unlocking new opportunities for clinicians, hospitals, and life sciences. 🔑 Key Benefits: • Enhanced trial recruitment and patient insights • Advanced data extraction for deeper research • A secure data network supporting global healthcare providers 📣 Jörg Stieg, Head of Analytics at #Dedalus, and Jeanne Kehren, CEO of LynxCare, both underscore the importance of data-driven transformation in healthcare, empowering research in #Oncology, #Cardiovascular Disease, #Immuno-Oncology, and beyond. Learn more about how we’re driving innovation in healthcare. 👉 https://lnkd.in/d_Cccm9H #HealthcareInnovation #AI #ClinicalResearch

Very happy to share the news that Hexoskin has raised an additional $4.2M to invest in digital biomarkers research and AI-based diagnostics! I'd like to thank our partners from AQC Capital, Anges Québec, BDC Capital (Canada), ballas invest (Europe), Deep Divers Ltd (UK), and 19 other US and Canadian investors for supporting our mission during these last few years when raising capital was challenging for most. A special thanks to Laurent van Lerberghe, Co-Founder of ballas invest and former Chief Strategy Officer at Sanofi for joining this round as an investor and advisor! Hexoskin’s team has over 15 years of experience in clinical AI development and high-resolution wearable sensors. Our partners understand how our digital platform is uniquely positioned to develop a range of diagnostic tests and digital solutions to address the needs of patients with cardiac, respiratory, neurological, and rare diseases.   Over the past 10 years, Hexoskin has built the largest ambulatory cardio-respiratory database in the world. The database includes hundreds of millions of breathing patterns and billions of cardiac rhythm patterns, in addition to sleep data and annotations specific to many other health conditions, developed with hospitals and research partners in the US, Canada, and Europe. It's been quite a journey since we started developing our first wearable sensors more than 15 years ago. Today we can finally say we have an end-to-end software solution for clinical research to serve our clients, from space medicine to Ivy League research labs, from pediatric research to research on aging. Our selection in the first cohort of the Mayo Clinic and ASU MedTech Accelerator program in 2019 confirmed our position as a global leader in health innovation. More information about the investment on our website: https://lnkd.in/gMNQwKGx Carré Technologies Inc., HITLAB, MEDTEQ+, Arizona BioIndustry Association (AZBio), Southern California Biomedical Council (SoCalBio), BIOQuebec, Montréal InVivo, Canadian Space Agency | Agence spatiale canadienne, Trade Commissioner Service | Service des délégués commerciaux, Frédéric Lovighi, Le Chiffre, YULEX, avocats et stratèges, s.e.n.c.r.l., KPMG #AI #clinicaltrials #medical #wearables #digitalbiomarkers #vc #angel #medtech #funding #startups #saas #digitalhealth #datascience

Today we want to give a shout out to ballas invest which has supported us since day one! 🙌🙌🙌 We're excited to have them as a sponsor for this year's edition of the HealthTech Investor Summit.   Paris-based Ballas Invest is an angel investor for European start-ups, specializing in funding artificial intelligence, decentralized clinical trials, and digital therapeutic solutions.   Come back to Bruges this December for a chance to meet and mingle with Ballas Invest and our other incredible sponsors!   https://lnkd.in/e4rhJe8H